P3 Health Partners Inc. (PIII)

P3 Health Partners Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-131.05	-135.85	-57.77	-270.13	-204.34	-31.41
Depreciation & Amortization	84.32	86.06	86.68	87.29	8.72	0.8
Other Amortization	11.46	0.09	0.47	-	1.8	0.23
Loss (Gain) From Sale of Assets	-4.87	-5.21	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	1,315	-	-
Stock-Based Compensation	5.2	5.75	5.98	19.4	8.34	0.45
Other Operating Activities	-158.04	-148.94	-141.68	-1,312	43.23	-20.54
Change in Accounts Receivable	40.08	-3.76	-42	-27.18	0.45	-27.37
Change in Accounts Payable	-2.1	-8.1	15.99	6.08	41.96	8.1
Change in Other Net Operating Assets	32.25	99.84	56.3	55.92	33.38	45.15
Operating Cash Flow	-122.75	-110.13	-76.03	-126.02	-66.47	-24.6
Capital Expenditures	-0.12	-	-1.83	-2.23	-3.41	-2.93
Sale of Property, Plant & Equipment	-0.43	14.53	-	-	-	-
Cash Acquisitions	-	-	-	-5.5	-52.87	-0.13
Other Investing Activities	-	-	-	-	0.21	-0.11
Investing Cash Flow	-0.54	14.53	-1.83	-7.73	-56.07	-3.17
Short-Term Debt Issued	-	1.87	-	-	3.73	-
Long-Term Debt Issued	-	88.06	14.1	15	25	36.43
Total Debt Issued	124.19	89.93	14.1	15	28.73	36.43
Long-Term Debt Repaid	-	-30.97	-	-3.63	-0.19	-1.49
Net Debt Issued (Repaid)	93.86	58.96	14.1	11.38	28.53	34.94
Issuance of Common Stock	0.02	40.53	86.6	-	195.31	-
Repurchase of Common Stock	-0.05	-0.1	-0.02	-	-	-0.18
Other Financing Activities	-0.18	-0.61	-0.35	-	-0.38	-
Financing Cash Flow	93.66	98.77	100.33	11.38	223.47	34.76
Net Cash Flow	-29.64	3.17	22.48	-122.38	100.93	7
Free Cash Flow	-122.87	-110.13	-77.86	-128.25	-69.88	-27.52
Free Cash Flow Margin	-8.50%	-7.34%	-6.15%	-12.22%	-10.96%	-5.61%
Free Cash Flow Per Share	-37.66	-37.46	-13.21	-154.23	-84.03	-20.90
Cash Interest Paid	14.19	14.19	5.81	5.71	4.14	0.69
Cash Income Tax Paid	5.48	5.48	0.57	-	-	-
Levered Free Cash Flow	-51.9	-4.59	-13.58	-33.15	-8.76	-18.74
Unlevered Free Cash Flow	-34.46	9.18	-4.06	-26.02	-3.88	-17.38
Change in Working Capital	70.23	87.98	30.3	34.82	75.78	25.89

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q